The invention relates to substituted 1-benzylquinoxalin-2(1H)-one analogs, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M1); methods for making the compounds; pharmaceutical compositions; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction.
本发明涉及替代的1-苄基喹噁啉-2(1H)-
酮类似物,其作为肌动蛋白
乙酰胆碱受体M1(mAChR M1)的正向异构调节剂是有用的。本发明还涉及制备所述化合物的方法、制药组合物以及治疗与肌动蛋白
乙酰胆碱受体功能障碍相关的神经和精神障碍的方法。